Literature DB >> 3940548

Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration.

C S Kitchens, J F Pendergast.   

Abstract

Capillary fragility is characteristic of severe thrombocytopenia. This mechanical weakness may not be solely accounted for by decreased ability of platelets to repair endothelial breaks. Platelets may have a role in maintaining endothelial hemostasis. This laboratory has demonstrated thinning of capillary endothelium in experimental thrombocytopenia. We now report similar findings in human thrombocytopenia. Capillary endothelium supplying either skin or skeletal muscle was found to have a mean thickness only half that of normal as well as frequent very thinned areas, including some fenestrations. All findings reverted toward normal after four days of prednisone administration at a time the degree of thrombocytopenia was equally severe. These findings are consistent with the hypothesis that platelets are necessary for normal structure and function of endothelial cells and that glucocorticosteroid administration may ameliorate the pathophysiology of thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940548

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Endothelial alterations in a canine model of immune thrombocytopenia.

Authors:  Dana N LeVine; Rachel E Cianciolo; Keith E Linder; Petra Bizikova; Adam J Birkenheuer; Marjory B Brooks; Abdelghaffar K Salous; Shila K Nordone; Dwight A Bellinger; Henry Marr; Sam L Jones; Thomas H Fischer; Yu Deng; Marshall Mazepa; Nigel S Key
Journal:  Platelets       Date:  2017-11-28       Impact factor: 3.862

2.  Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury.

Authors:  William Bain; Tolani Olonisakin; Minting Yu; Yanyan Qu; Mei Hulver; Zeyu Xiong; Huihua Li; Joseph Pilewski; Rama K Mallampalli; Mehdi Nouraie; Anuradha Ray; Prabir Ray; Zhenyu Cheng; Robert M Q Shanks; Claudette St Croix; Roy L Silverstein; Janet S Lee
Journal:  Blood Adv       Date:  2019-02-12

Review 3.  Idiopathic thrombocytopenic purpura of childhood.

Authors:  A Emami
Journal:  Indian J Pediatr       Date:  1987 May-Jun       Impact factor: 1.967

Review 4.  Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity.

Authors:  Yacine Boulaftali; Paul R Hess; Mark L Kahn; Wolfgang Bergmeier
Journal:  Circ Res       Date:  2014-03-28       Impact factor: 17.367

Review 5.  Management of immune thrombocytopenic purpura in children: potential role of novel agents.

Authors:  Amy Lee Bredlau; John W Semple; George B Segel
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

Review 6.  How platelets safeguard vascular integrity.

Authors:  B Ho-Tin-Noé; M Demers; D D Wagner
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

Review 7.  Platelets in lung biology.

Authors:  Andrew S Weyrich; Guy A Zimmerman
Journal:  Annu Rev Physiol       Date:  2012-10-01       Impact factor: 19.318

8.  A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs?

Authors:  Dana N LeVine; Adam J Birkenheuer; Marjory B Brooks; Shila K Nordone; Dwight A Bellinger; Sam L Jones; Thomas H Fischer; Stephen E Oglesbee; Kahlina Frey; Nicole S Brinson; Allison P Peters; Henry S Marr; Alison Motsinger-Reif; Sif Gudbrandsdottir; James B Bussel; Nigel S Key
Journal:  Br J Haematol       Date:  2014-07-08       Impact factor: 6.998

9.  Hemostasis vs. homeostasis: Platelets are essential for preserving vascular barrier function in the absence of injury or inflammation.

Authors:  Shuchi Gupta; Christoph Konradt; Adam Corken; Jerry Ware; Bernhard Nieswandt; Jorge Di Paola; Mei Yu; Demin Wang; Marvin T Nieman; Sidney W Whiteheart; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-14       Impact factor: 11.205

Review 10.  Current Management of Primary Immune Thrombocytopenia.

Authors:  Drew Provan; Adrian C Newland
Journal:  Adv Ther       Date:  2015-10-26       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.